Ladenburg Thalmann Downgrades ReShape Lifesciences Inc (RSLS) to Neutral
Tweet
Share
E-mailGet Alerts RSLS Hot Sheet
Price: $3.92 --0%
Rating Summary:
1 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
1 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
Ladenburg Thalmann downgraded ReShape Lifesciences Inc (NASDAQ: RSLS) from Buy to Neutral.
Analyst Jeff Cohen cites increasing uncertainty relating to the company's ability to execute and finance current/anticipated strategic plans.
For an analyst ratings summary and ratings history on ReShape Lifesciences Inc click here. For more ratings news on ReShape Lifesciences Inc click here.
Shares of ReShape Lifesciences Inc closed at $0.53 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Downgrades Vicinity Centers (VCX:AU) (CNRAF) to Neutral
- JPMorgan Downgrades Rockwool (ROCKB:DC) (RKWBF) to Neutral
- TD Cowen Downgrades Roots Corp. (ROOT:CN) (RROTF) to Sell
Create E-mail Alert Related Categories
Analyst Comments, DowngradesRelated Entities
Ladenburg Thalmann Financial ServicesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
